These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 23897230

  • 21. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS, Carpenter MA, Ivanova A, Gravens-Mueller L, John AA, Weir MR, Pesavento T, Bostom AG, Pfeffer MA, Hunsicker LG.
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [Abstract] [Full Text] [Related]

  • 22. Chronic kidney disease after orthotopic liver transplantation in recipients receiving tacrolimus.
    Garces G, Contreras G, Carvalho D, Jaraba IM, Carvalho C, Tzakis A, Moon J, Ratnam K, Roth D.
    Clin Nephrol; 2011 Feb; 75(2):150-7. PubMed ID: 21255545
    [Abstract] [Full Text] [Related]

  • 23. Progression to Stage 4 chronic kidney disease and death, acute kidney injury and hospitalization risk: a retrospective cohort study.
    Sud M, Tangri N, Pintilie M, Levey AS, Naimark DM.
    Nephrol Dial Transplant; 2016 Jul; 31(7):1122-30. PubMed ID: 26590389
    [Abstract] [Full Text] [Related]

  • 24. Short-term change in kidney function and risk of end-stage renal disease.
    Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR.
    Nephrol Dial Transplant; 2012 Oct; 27(10):3835-43. PubMed ID: 22764191
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan.
    Saito T, Mochizuki T, Uchida K, Tsuchiya K, Nitta K.
    Heart Vessels; 2013 May; 28(3):323-9. PubMed ID: 22526382
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of kidney diseases on survival in liver transplant patients.
    Süleymanlar I, Yılmaz VT, Koçak H, Dinçkan A, Gürkan A, Ersoy F, Süleymanlar G.
    Int Urol Nephrol; 2011 Sep; 43(3):827-33. PubMed ID: 20686843
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients.
    Di Maira T, Rubin A, Puchades L, Aguilera V, Vinaixa C, Garcia M, De Maria N, Villa E, Lopez-Andujar R, San Juan F, Montalva E, Perez J, Prieto M, Berenguer M.
    Liver Transpl; 2015 Jun; 21(6):812-22. PubMed ID: 27396823
    [Abstract] [Full Text] [Related]

  • 33. Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study.
    Choi HY, Huh KH, Lee JG, Song MK, Kim MS, Kim YS, Kim BS.
    PLoS One; 2016 Jun; 11(12):e0168337. PubMed ID: 27973553
    [Abstract] [Full Text] [Related]

  • 34. Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: A single-center examination of updated UNOS recommendations.
    Chauhan K, Azzi Y, Faddoul G, Liriano-Ward L, Chang P, Nadkarni G, Delaney V, Ames S, Debnath N, Singh N, Sehgal V, Di Boccardo G, Garzon F, Nair V, Kent R, Lerner S, Coca S, Shapiro R, Florman S, Schiano T, Menon MC.
    Clin Transplant; 2018 Dec; 32(12):e13428. PubMed ID: 30338873
    [Abstract] [Full Text] [Related]

  • 35. Mitral valve repair for medically refractory functional mitral regurgitation in patients with end-stage renal disease and advanced heart failure.
    Kainuma S, Taniguchi K, Daimon T, Sakaguchi T, Funatsu T, Miyagawa S, Kondoh H, Takeda K, Shudo Y, Masai T, Ohishi M, Sawa Y.
    Circulation; 2012 Sep 11; 126(11 Suppl 1):S205-13. PubMed ID: 22965985
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
    Khandoga A, Iskandarov E, Angele M, Gerbes A, Frey L, Ağayev B, Jauch KW, Werner J, Guba M.
    Eur J Gastroenterol Hepatol; 2016 Feb 11; 28(2):153-8. PubMed ID: 26545081
    [Abstract] [Full Text] [Related]

  • 38. Hyperuricemia after orthotopic liver transplantation: divergent associations with progression of renal disease, incident end-stage renal disease, and mortality.
    Longenecker JC, Waheed S, Bandak G, Murakami CA, McMahon BA, Gelber AC, Atta MG.
    BMC Nephrol; 2017 Mar 27; 18(1):103. PubMed ID: 28347282
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Long-term outcomes of community-acquired versus hospital-acquired acute kidney injury: a retrospective analysis.
    Der Mesropian PJ, Kalamaras JS, Eisele G, Phelps KR, Asif A, Mathew RO.
    Clin Nephrol; 2014 Mar 27; 81(3):174-84. PubMed ID: 24361059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.